📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
6 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
46
ALNY Stock Analysis & AI Grade: HIGH
6 articles analyzed · Sentiment: BULLISH · AI-powered equity research
RECENT COVERAGE · 6 ARTICLES
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2026 Earnings Call Transcript
Alnylam Pharmaceuticals (ALNY) released Q2 2026 earnings results via earnings call transcript. The availability of the official call...
Alnylam Pharma Reports Net Income In Q2; Revises 2026 TTR Net Product Revenue Guidance
Alnylam Pharmaceuticals (ALNY) achieved a significant inflection point in Q2 profitability, posting $164.5 million in net income versus...
Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation
Alnylam Pharmaceuticals (ALNY) delivered record operational performance in its latest quarter, underscoring strengthening fundamentals...
Alnylam Pharmaceuticals: Commercial Momentum Outweighs TTR Read-Through Concerns (NASDAQ:ALNY)
Alnylam Pharmaceuticals (ALNY) is being reassessed by analysts as commercial execution and financial strength offset concerns around TTR...
Morgan Stanley Raises its Price Target on Alnylam (ALNY)
Alnylam (ALNY) has attracted multiple analyst price target increases, with Morgan Stanley raising its target to $400 from $370 while...
10 Best Growth Stocks With Highest Upside Potential
BlackRock's commentary on broadening earnings strength signals a potential rotation away from concentrated Magnificent Seven dominance...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice